Skip to content

Manchester Asthma and Allergy Study (MAAS) age 25 plus follow up

Manchester Asthma and Allergy Study (MAAS) age 25 plus follow up

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN43561070
Enrollment
500
Registered
2025-08-26
Start date
2026-02-04
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma and allergic diseases Respiratory

Interventions

The study will comprise a single visit lasting approximately 2 hours. During the visit the study participants will complete questionnaires, lung function tests, skin prick tests and have blood taken.
blood pressure, heart rate and pulse oximetry. Skin prick testing to a panel of inhalant and food allergens (including house dust mite, cat, dog, grass, trees, mould, milk, egg, peanut, hazelnut, wal

Sponsors

University of Manchester
Lead Sponsor

Eligibility

Sex/Gender
All
Age
24 Years to 34 Years

Inclusion criteria

Inclusion criteria: Membership of MAAS Birth Cohort

Exclusion criteria

Exclusion criteria: Not member of MAAS birth cohort

Design outcomes

Primary

MeasureTime frame
Prevalence of asthma in the cohort, as defined by responses to the respiratory questionnaire measured at a single time point

Secondary

MeasureTime frame
Measured at a single time point: 1. Prevalence of eczema, hay fever and food allergy as defined by questionnaires 2. Prevalence of allergy to inhalant allergens (dust mite cat and dog and pollen) and to foods 3. Classes of trajectories of measures of lung function (to identify predictors) 4. Classes of wheezing illness - defined by frequency of episodes and exacerbations 5. Measurement of CC16 in relation to asthma and lung function outcomes 6. Classes of exposure to outdoor air pollutants - to relate to clinical outcomes

Countries

England, United Kingdom

Contacts

Public ContactClare;Gina Murray;Kerry

;

clare.murray@manchester.ac.uk;gina.kerry@mft.nhs.uk+44 161 291 5818;+44 161 9987070

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 30, 2026